Assay optimization and screening for measuring the kinetics of antibacterial resistance emergence
Assay optimization and screening for measuring the kinetics of antibacterial resistance emergence
批准号:
10919706
负责人:
Anton Simeonov
金额:
$12.58万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AddressAntibiotic ResistanceBacterial Drug ResistanceBacterial InfectionsBiological AssayClinicalCombined Modality TherapyDrug CombinationsDrug KineticsDrug resistanceFiberInfectionKineticsLiquid substanceMeasuresModelingNational Center for Advancing Translational SciencesPharmaceutical PreparationsPublic HealthSystemminiaturizeresponsescreening
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Antibiotic resistance is one of the major threats to public health today. To address this problem requires an urgent comprehensive approach. Strategic and multi-targeted combination therapy has been increasingly used clinically to treat bacterial infections. Collaborators at the FDA have developed a hollow-fibre infection model to assess the emergence of drug resistance in response to drug combinations (2 and 3 drugs), however, this is limited in its throughput. To address this, the project team is leveraging NCATS's liquid handling capabilities to screen bacterial responses to combinations and measure the kinetics of the emergence of drug resistance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PRKACA for Fibrolamellar hepatocellular carcinoma
-
批准号:9554490
-
项目类别:
-
资助金额:$4.47万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
MST/ITC studies on Vimentin DHA interaction
-
批准号:9554499
-
项目类别:
-
资助金额:$4.47万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Disrupting Type IV secretion function to prevent virulence in the pathogenic bacterium Legionella pneumophila
-
批准号:9554502
-
项目类别:
-
资助金额:$13.57万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
High-throughput multiparametric drug screening method for 3D spheroids
-
批准号:9554522
-
项目类别:
-
资助金额:$4.47万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Identification of Grb10:Insulin Receptor Disruptors
-
批准号:9554524
-
项目类别:
-
资助金额:$4.47万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
A Novel Compound for Targeted Treatment of CBF Leukemia
-
批准号:9354952
-
项目类别:
-
资助金额:$176.51万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Trans-NIH RNAi Facility (TNRF)
-
批准号:9205806
-
项目类别:
-
资助金额:$47.5万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
A Novel Compound for Targeted Treatment of CBF Leukemia
-
批准号:9205569
-
项目类别:
-
资助金额:$200.38万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
A Novel Compound for Targeted Treatment of CBF Leukemia
-
批准号:9550575
-
项目类别:
-
资助金额:$205.31万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Profliing Assay for Redox Potential
-
批准号:9772066
-
项目类别:
-
资助金额:$4.08万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Protein Kinase CAMP-Activated Catalytic Subunit Alpha
-
批准号:9554489
-
项目类别:
-
资助金额:$4.47万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Identification of Myc translation inhibitors
-
批准号:9554527
-
项目类别:
-
资助金额:$4.47万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Helping to End Addiction Long-term (HEAL): Induced Pluripotent Stem Cell (iPSC)-Derived Cell Types for Pain, Addiction and Overdose
-
批准号:10908193
-
项目类别:
-
资助金额:$92.71万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
15-hLO-1 inhibitors as Potential Therapeutics Against Stroke
-
批准号:10011389
-
项目类别:
-
资助金额:$13.27万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Screening to identify potent and specific inhibitors of N-terminal methyltransferase (NTMT1) as chemical probes
-
批准号:10011397
-
项目类别:
-
资助金额:$13.27万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Identification of small molecule inhibitors of USP8
-
批准号:10011437
-
项目类别:
-
资助金额:$4.76万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Assay Guidance Manual
-
批准号:10011458
-
项目类别:
-
资助金额:$3.37万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Activation-induced cytidine deaminase
-
批准号:10011394
-
项目类别:
-
资助金额:$25.03万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
qHTS to Identify Inhibitors of Rabies Virus
-
批准号:10011405
-
项目类别:
-
资助金额:$13.27万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
Identification of inhibitors of Zika Protease (NS2B-NS3)
-
批准号:10005788
-
项目类别:
-
资助金额:$13.27万
-
财政年份:--
-
负责人:Anton Simeonov
-
依托单位:
海外基金